Back
CHEK2HGNC PubMed

Recent advances in genetic predisposition to primary testicular tumors.

Siegmund SESemin Diagn Pathol 2026 · May 2026
Relevance score
5/10
Disease / domain
Genetic predisposition to primary testicular tumors (germ cell and stromal)
Source
PubMed
PMID 42151003
Share on LinkedIn

Gene / mechanism

Review of recent advances in genetic predisposition to testicular tumors: polygenic model for germ cell tumors (GCT), first moderate-penetrance gene (CHEK2), hereditary syndrome associations for stromal tumors

Summary

This review summarizes advances in genetic predisposition to testicular tumors. For germ cell tumors (95% of cases), a polygenic model is firmly established (cumulative low-penetrance common variants from GWAS), while CHEK2 has just been identified as the first moderate-penetrance gene for this indication. For gonadal stromal tumors, associations with Mendelian syndromes are well established: Carney complex (PRKAR1A), Peutz-Jeghers (STK11), HLRCC (FH), and potentially FAP (APC) and DICER1 syndrome.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

The identification of CHEK2 as the first moderate-penetrance gene for testicular germ cell tumors is a notable advance worth integrating into cancer predisposition panels. For clinicians, this review helps identify patients with rare (stromal) testicular tumors who warrant hereditary syndrome workup — a diagnostic reflex still insufficiently established.

Why this score?

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 0/1 · Journal quality: 0/1 → Total: 5/10

Keywords

testicular cancerCHEK2genetic predispositiongerm cell tumorsmoderate penetrance
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime